undamentalytics Newsletter

Clearpoint Neuro vs Koru Medical Systems

Clearpoint Neuro and Koru Medical Systems are similar in size: $37.0m and $41.1m of revenue in their latest fiscal years. Koru Medical Systems grew faster (22.2% against 17.8%). Koru Medical Systems kept more of each dollar of sales as profit: a net margin of -6.4% against -69.1%.

Latest fiscal yearClearpoint NeuroCLPT, 2025Koru Medical SystemsKRMD, 2025
Revenue $37.0m $41.1m
Revenue growth 17.8% 22.2%
Net income −$25.5m −$2.6m
Operating margin — -7.2%
Net margin -69.1% -6.4%
Return on equity -95.6% -15.6%
Free cash flow −$24.4m −$470,112
Cash $45.9m $8.9m
Total debt $50.9m $0
Debt to equity — 0.0%
Dividend per share — —
Dividend yield — —
Share buybacks — —
Employees 172 73
Market value $310m $143m
Price vs our value range — —
Moat score 30 (Weak) 46 (Moderate)
Insider trades, 12 months 0 buys, 9 sales 9 buys, 0 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.